NGAL

Choose the Best Products for Your Unique Needs

NGAL

Recombinant NGAL (Neutrophil Gelatinase Associated Lipocalin) is produced in E. coli and purified by column chromatography. NGAL is widely used as an early diagnostic biomarker for acute kidney injury (AKI) and other renal disorders. This recombinant form is aseptically filtered and formulated in 50 mM Sodium Phosphate and 0.15 M Sodium Chloride with 50% glycerol (pH 7.4 ± 0.2), ensuring high purity and stability for diagnostic assay development.

Parameter	Details
Source	Recombinant (Transformed E. coli)
Application	Suitable for immunoassays, calibrators, controls, research diagnostics, AKI biomarker assay development
Purity Analysis	SDS-PAGE ≥ 95% — Passes; Concentration: 0.69 mg/mL (Immunonephelometry)
Immunological Activity	Appearance: Clear to colorless — Passes
Presentation	Liquid (aseptically filtered), 50 mM Sodium Phosphate, 0.15 M Sodium Chloride, 50% Glycerol; pH 7.4 ± 0.2
Storage	-20°C in working aliquots; avoid freeze–thaw cycles
Other Information	Accession No.: P80188 (107-C→S mutant); Grade: Pure
Bioburden	<10 CFU/mL — Passes
Viral Testing	Not applicable (recombinant E. coli origin)
Material Safety Note	Not for human or animal consumption; for in-vitro research use only. Follow biosafety precautions and discard as per regulatory guidelines.

Download Datasheet

Refer Datasheet

IVD

IDD

IVD SERVICES

IDD SERVICES

IVD

IDD

IVD SERVICES

IDD SERVICES

IVD

IDD

IVD SERVICES

IDD SERVICES

IVD

IDD

IVD SERVICES

IDD SERVICES

NGAL

NGAL

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6